These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3116083)
1. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. Calman AF; Peterlin BM J Immunol; 1987 Oct; 139(7):2489-95. PubMed ID: 3116083 [TBL] [Abstract][Full Text] [Related]
2. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages. Maffei A; Scarpellino L; Bernard M; Carra G; Jotterand-Bellomo M; Guardiola J; Accolla RS J Immunol; 1987 Aug; 139(3):942-8. PubMed ID: 3110290 [TBL] [Abstract][Full Text] [Related]
3. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells. Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411 [TBL] [Abstract][Full Text] [Related]
4. MHC class II transcription in different mouse cell types. Differential requirement for protein synthesis between B cells and macrophages. Woodward JG; Omer KW; Stuart PM J Immunol; 1989 Jun; 142(11):4062-9. PubMed ID: 2497189 [TBL] [Abstract][Full Text] [Related]
5. A phenotypically dominant regulatory mechanism suppresses major histocompatibility complex class II gene expression in a murine plasmacytoma. Venkitaraman AR; Culbert EJ; Feldmann M Eur J Immunol; 1987 Oct; 17(10):1441-6. PubMed ID: 3500056 [TBL] [Abstract][Full Text] [Related]
6. Translational control of MHC class II I-A molecules by IFN-gamma. Goñalons E; Barrachina M; García-Sanz JA; Celada A J Immunol; 1998 Aug; 161(4):1837-43. PubMed ID: 9712051 [TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K; Meehan RR; Dewar AE; Larhammar D Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139 [TBL] [Abstract][Full Text] [Related]
9. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
10. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival. Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1). Noelle RJ; Kuziel WA; Maliszewski CR; McAdams E; Vitetta ES; Tucker PW J Immunol; 1986 Sep; 137(5):1718-23. PubMed ID: 3489040 [TBL] [Abstract][Full Text] [Related]
12. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules. Wilson KM; Labeta MO; Pawelec G; Fernandez N Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710 [TBL] [Abstract][Full Text] [Related]
13. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488 [TBL] [Abstract][Full Text] [Related]
14. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. Muczynski KA; Anderson SK; Pious D J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276 [TBL] [Abstract][Full Text] [Related]
15. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines. Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223 [TBL] [Abstract][Full Text] [Related]
16. Regulation of class II gene expression in a murine pre-B cell line. Polla BS; Poljak A; Geier S; Nathenson SG; Ohara J; Paul WE; Glimcher LH Fed Proc; 1986 Dec; 45(13):2995-9. PubMed ID: 3536599 [TBL] [Abstract][Full Text] [Related]
17. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
18. Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. Sartoris S; Scupoli MT; Scarpellino L; Paiola F; Jotterand-Bellomo M; Tridente G; Accolla RS J Immunol; 1990 Sep; 145(6):1960-7. PubMed ID: 2391425 [TBL] [Abstract][Full Text] [Related]
19. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807 [TBL] [Abstract][Full Text] [Related]
20. Complex regulation of class II gene expression: analysis with class II mutant cell lines. Glimcher LH; McKean DJ; Choi E; Seidman JG J Immunol; 1985 Nov; 135(5):3542-50. PubMed ID: 2995495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]